The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance.

Article English OPEN
Gifford, RJ ; Liu, TF ; Rhee, SY ; Kiuchi, M ; Hue, S ; Pillay, D ; Shafer, RW (2009)
  • Publisher: Oxford University Press (OUP)
  • Journal: Bioinformatics, volume 25, issue 9, pages 1,197-1,198 (issn: 1367-4803, eissn: 1460-2059)
  • Related identifiers: doi: 10.1093/bioinformatics/btp134, pmc: PMC2672634
  • Subject: Sequence Analysis | Applications Note
    mesheuropmc: education | health care economics and organizations | health services administration | natural sciences
    acm: ComputingMethodologies_PATTERNRECOGNITION | GeneralLiterature_MISCELLANEOUS

Summary: The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug resistance. The program is linked to the Stanford HIV drug resistance database and can additionally perform viral genotyping and algorithmic estimation of resistance to specific antiretroviral drugs. Availability: http://cpr.stanford.edu/cpr/index.html Contact: robjgiff@gmail.com
  • References (19)
    19 references, page 1 of 2

    Bennett,D.E. et al. (2008a) The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir. Ther., 13(Suppl. 2), 1-13.

    Bennett,D.E. et al. (2008b) Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir. Ther., 13 (Suppl. 2), 25-36.

    Bertagnolio,S. et al. (2007) HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther., 12, 107-113.

    Gifford,R.J. et al. (2008) Sequence editing by Apolipoprotein B RNA-editing catalytic component and epidemiological surveillance of transmitted HIV-1 drug resistance. AIDS, 22, 717-725.

    Gilks,C.F. et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet, 368, 505-510.

    Holmes,R.K. et al. (2007) APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci., 32, 118-128.

    Huang,X. and Zhang,J. (1996) Methods for comparing a DNA sequence with a protein sequence. Comput. Appl. Biosci., 12, 497-506.

    Kuritzkes,D.R. et al. (2008) Preexisting resistance to nonnucleoside reversetranscriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects. J. Infect. Dis., 197, 867-870.

    Little,S.J. et al. (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N. Engl. J. Med., 347, 385-394.

    Liu,T.F. and Shafer,R.W. (2006) Web resources for HIV type 1 genotypic-resistance test interpretation. Clin. Infect. Dis., 42, 1608-1618.

  • Metrics
    No metrics available
Share - Bookmark